|
1
|
Suzuki T, Yajima S, Okamura A, Yoshida N, Taniyama Y, Murakami K, Ohkura Y, Nakajima Y, Yagi K, Fukuda T, et al: Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: Multi-institutional study of the Japan Esophageal Society. Dis Esophagus. 35(doac029)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuhet M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA. 92:11810–11813. 1995.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, Matsubara H, Nomura F, Takiguchi M and Hiwasa T: Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer. 112:1029–1035. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kuboshima M, Shimada H, Liu TL, Nakashima K, Nomura F, Takiguchi M, Hiwasa T and Ochiai T: Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma. Int J Oncol. 28:463–468. 2006.PubMed/NCBI
|
|
5
|
Ito M, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Takizawa H, et al: Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers. Mol Clin Oncol. 15(237)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sumazaki M, Shimada H, Ito M, Shiratori F, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Iwadate Y, Mine S, et al: Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases. Cancer Sci. 111:4453–4464. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ito M, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Li SY, et al: Association of serum anti-PCSK9 antibody levels with favorable postoperative prognosis in esophageal cancer. Front Oncol. 11(708039)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ito M, Hiwasa T, Yajima S, Suzuki T, Oshima Y, Nanami T, Sumazaki M, Shiratori F, Li SY, Iwadate Y, et al: Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma. Esophagus. 19:617–625. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Daryabari SS, Fathi M, Mahdavi M, Moaddab Y, Hosseinpour Feizi MA, Shokoohi B and Safaralizadeh R: Overexpression of CFL1 in gastric cancer and the effects of its silencing by siRNA with a nanoparticle delivery system in the gastric cancer cell line. J Cell Physiol. 235:6660–6672. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li X, Ma G, Guo W, Mu N, Wang Y, Liu X and Su L: Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells. Cell Commun Signal. 19(80)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Werle SD, Schwab JD, Tatura M, Kirchhoff S, Szekely R, Diels R, Ikonomi N, Sipos B, Sperveslage J, Gress TM, et al: Unraveling the molecular tumor-promoting regulation of cofilin-1 in pancreatic cancer. Cancers (Basel). 13(725)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li J, Brieher WM, Scimone ML, Kang SJ, Zhu H, Yin H, von Andrian UH, Mitchison T and Yuan J: Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization. Nat Cell Biol. 9:276–286. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu L, Liu J, Shimada H, Ito M, Sugimoto K, Hiwasa T, Zhou Q, Li J, Shen S and Wang H: Serum anti-BRAT1 is a common molecular biomarker for gastrointestinal cancers and atherosclerosis. Front Oncol. 12(870086)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu J, Wan P, Wang M, Zhang J, Gao X, Hu B, Han J, Chen L, Sun K, Wu J, et al: AIP1-mediated actin disassembly is required for postnatal germ cell migration and spermatogonial stem cell niche establishment. Cell Death Dis. 6(e1818)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kagaya A, Shimada H, Shiratori T, Kuboshima M, Nakashima-Fujita K, Yasuraoka M, Nishimori T, Kurei S, Hachiya T, Murakami A, et al: Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma. Proteome Sci. 9(31)2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Konzok A, Weber I, Simmeth E, Hacker U, Maniak M and Muller-Taubenberger A: DAip1, a dictyostelium homologue of the yeast actin-interacting protein 1, is involved in endocytosis, cytokinesis, and motility. J Cell Biol. 146:453–464. 1999.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kimura R, Mine S, Kamitsukasa I, Wada T, et al: Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget. 9:5600–5613. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sugimoto K, Mori M, Liu J, Shibuya K, Isose S, Koide M, Hiwasa T and Kuwabara S: Novel serum autoantibodies against β-actin (ACTB) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 22:388–394. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shimada H, Shiratori T, Yasuraoka M, Kagaya A, Kuboshima M, Nomura F, Takiguchi M, Ochiai T, Matsubara H and Hiwasa T: Identification of makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. BMC Cancer. 9(232)2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Machida T, Kubota M, Kobayashi E, Iwadate Y, Saeki N, Yamaura A, Nomura F, Takiguchi M and Hiwasa T: Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX). J Transl Med. 13(71)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li SY, Yoshida Y, Kobayashi E, Adachi A, Hirono S, Matsutani T, Mine S, Machida T, Ohno M, Nishi E, et al: Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension. Int J Mol Med. 46:1274–1288. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shimada H, Ochiai T and Nomura F: Japan p53 Antibody Research Group. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: A multiinstitutional analysis by the Japan p53 Antibody Research Group. Cancer. 97:682–689. 2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, et al: Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer. 89:1677–1683. 2000.PubMed/NCBI
|
|
24
|
Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H and Ochiai T: Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery. 133:486–494. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Camp RL, Dolled-Filhart M and Rimm DL: X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 10:7252–7259. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kanda Y: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, Cheng DQ, Weng WH, Wu XS, Fei XZ, et al: Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 281:71–81. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lambert AW, Pattabiraman DR and Weinberg RA: Emerging biological principles of metastasis. Cell. 168:670–691. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim DH, Bae J, Lee JW, Kim SY, Kim YH, Bae JY, Yi JK, Yu MH, Noh DY and Lee C: Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness. Proteomics Clin Appl. 3:30–40. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Izawa S, Okamura T, Matsuzawa K, Ohkura T, Ohkura H, Ishiguro K, Noh JY, Kamijo K, Yoshida A, Shigemasa C, et al: Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia. Clin Endocrinol. 79:35–42. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Haslene-Hox H, Oveland E, Woie K, Salvesen HB, Wiig H and Tenstad O: Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue. Biochim Biophys Acta. 1834:2347–2359. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xu H, Chen Y, Tan C, Xu T, Yan Y, Qin R, Huang Q, Lu C, Liang C, Lu Y, et al: High expression of WDR1 in primary glioblastoma is associated with poor prognosis. Am J Transl Res. 8:1253–1264. 2016.PubMed/NCBI
|
|
33
|
Talman AM, Chong R, Chia J, Svitkina T and Agaisse H: Actin network disassembly powers dissemination of Listeria monocytogenes. J Cell Sci. 127(Pt 1):240–249. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shoji K, Ohashi K, Sampei K, Oikawa M and Mizuno K: Cytochalasin D acts as an inhibitor of the actin-cofilin interaction. Biochem Biophys Res Commun. 424:52–57. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Utomo DH, Fujieda A, Tanaka K, Takahashi M, Futaki K, Tanabe K, Kigoshi H and Kita M: The C29-C34 parts of antitumor macrolide aplyronine A serve as versatile actin-affinity tags. Chem Commun (Camb). 57:10540–10543. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Japan Esophageal Society. Japanese classification of esophageal cancer, 11th Edition: Part II and III. Esophagus. 14:37–65. 2017.PubMed/NCBI View Article : Google Scholar
|
